Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 30;4(2):e00208.
doi: 10.1002/edm2.208. eCollection 2021 Apr.

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations

Lina Merjaneh  1   2 , Demet Toprak  2   3 , Sharon McNamara  3 , Laura Nay  3 , Erin Sullivan  4 , Margaret Rosenfeld  2   3
Affiliations

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations

Lina Merjaneh et al. Endocrinol Diabetes Metab. .

Abstract

Background: Hyperglycaemia may contribute to failure to recover from pulmonary exacerbations in cystic fibrosis (CF). We aimed to evaluate the prevalence and mechanism of hyperglycaemia during and post-exacerbations.

Methods: Nine paediatric CF patients, not on insulin, hospitalized for intravenous antibiotics, underwent an oral glucose tolerance test (OGTT) and continuous glucose monitoring (CGM) upon admission (visit 1) and an OGTT 2 weeks (visit 2) and 6 weeks to 12 months later when at stable baseline (visit 3). Insulin and glucose levels were measured before, 30, 60 and 120 min after glucose ingestion during OGTT. Hyperglycaemia on OGTT was defined according to the American Diabetes Association criteria as abnormal OGTT or consistent with diabetes. Hyperglycaemia on CGM was defined as CGM time above 140 mg/dL > 4.5%.

Results: At visit 1, 8/9 patients had hyperglycaemia on both CGM and OGTT (2 diabetes and 6 abnormal OGTT). At visit 2, 5/8 had hyperglycaemia (all abnormal OGTT). At visit 3, (median (IQR) time since visit 1, 4.9 (3.8-6.3) months), 5/7 had hyperglycaemia (2 diabetes and 3 abnormal OGTT). At visits 1, 2 and 3, respectively, mean (SD) 2-hour OGTT glucose was 175.8 (42.3), 146.3 (31.9) and 176.9 (51.7) mg/dL. CGM time above 140 mg/dL at visit 1 was 25.3% (16.9). Insulin AUC decreased from visit 2 (median (IQR) 5449 (3321-8123) mcIU-min/mL) to visit 3 (3234 (2913-3680) mcIU-min/mL).

Conclusion: Hyperglycaemia is prevalent during paediatric CF exacerbations; it appears to improve with exacerbation treatment but to worsen later in association with decreased insulin secretion.

Keywords: continuous glucose monitoring; cystic fibrosis‐related diabetes; hyperglycaemia; insulin; oral glucose tolerance test.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
A and B, Distribution of 2‐hour glucose: prior to exacerbations, at baseline, 2 weeks and outpatient follow‐up
FIGURE 2
FIGURE 2
A and B, Distribution of 1‐hour glucose: at baseline, 2 weeks and outpatient follow‐up
FIGURE 3
FIGURE 3
A, Distribution of glucose AUC: at baseline, 2 weeks and outpatient follow‐up. B, Distribution of insulin AUC: at baseline, 2 weeks and outpatient follow‐up
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182(5):627‐632. 10.1164/rccm.200909-1421OC - DOI - PMC - PubMed
    1. de Boer K, Vandemheen KL, Tullis E, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011;66(8):680‐685. 10.1136/thx.2011.161117 - DOI - PubMed
    1. Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. J Pediatr. 2006;148(2):259‐264. 10.1016/j.jpeds.2005.10.019 - DOI - PubMed
    1. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992;151(9):684‐687. 10.1007/BF01957574 - DOI - PubMed
    1. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 1994;83(8):849‐853. 10.1111/j.1651-2227.1994.tb13156.x - DOI - PubMed

Publication types